Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Double Profits .. Ex David Southwood. " The new model and FCA approvals are expected to yield higher margins and accelerated growth in profitability from 2017 as we migrate funds and benefit from providing a wider product offering to a larger potential customer base. As announced on 14 March 2016, the Board's expectations are that in the financial year ending 31 December 2017, we are comfortably on track, given no unforeseen external influences, to double operating profitability from that reported for the financial year ended 31 December 2015. What's not to like.
Director Buys - Another massive vote of confidence by our board in acquiring shares from a long standing holder who continues to hold 6% + of the company and bought into this company at many multiples less than they were sold for. The most recent acquisition will make a significant increase in their operating profit and will reflect well on their strategies imo.
We most recently saw Henderson and Harwood buy out approx 40M shares from Schoeder at circa 11p. If the company needed more cash both these players are incentivised to do so....£2M would seem reasonable considering initial company report on cashflow positive by April. So no big shakes. IMO.
Not long to find out. " RNS 3.2.16 2016 - The year ahead As we rebase the Company, it is key that the expectations are set at a level that reflects the core business without the inclusion of tender business, which has been an Achilles heel in the past. On that basis the Board anticipates core 2016 revenues, without tender wins, being just over £30 million with an adjusted EBITDA between £3 million and £4 million. The Board believe that we can and should achieve more, but we have decided that we are unable to accurately forecast the tender business due to the vagaries of public funding leading to delays and postponements. In terms of our cash; our facility was reduced and I have supported the Company by making funds available to enable executive management to perform the task that I had set them. In the first quarter cash remains tight due to the impact of the costs associated with restructuring but thereafter the benefits of the cost reductions flow through and we expect to be cash positive by April 2016. I have leveraged my expertise and network to look to expand our distribution in areas where we are currently weak and it is my ambition to make this Company a major player in Point-of-Care. With both the distractions and under-performance of 2015 behind EKF, I believe we now have all the foundations in place to be able to build and deliver on this and have considerable prospects for future growth.
Adastra, it couldn't be Ron Z or one of his trusts that bought the 40+ M shares today due to the closed period. I had initially wondered if he had made a grab for more shares whilst they were low. Somebody else is interested. Pontil
Adastra, I recall you posted the major shareholdings. Here's the latest from the website. Been reliably informed by a helpful person that it couldn't be Ron as he is in a closed period! DYOR. Significant shareholders No. of ordinary shares % held Schroders plc 48,943,615 11.60% Zwanziger Family Ventures 33,661,694 7.98% Oryx International Growth Fund Limited 32,500,000 7.70% Henderson Global Investors 31,650,028 7.50% Legal & General Investment Management 19,214,079 4.55% Invesco Asset Management 17,306,163 4.10% Mr William Pippin 16,189,675 3.84% Nexus Medical Partners 14,496,000 3.43% Harwood Capital 14,311,379 3.39%